Skip to main content

Maria Martinez Martinez

Institutions of which they are part

Main researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Maria Martinez Martinez

Institutions of which they are part

Main researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Projects

Shock, Disfunció Orgànica i Ressucitació

IP: Ricard Ferrer Roca
Collaborators: César Laborda Soriano, Alejandra García Roche, Candido Diaz Lagares, Rosa Maria Gracia Gozalo, Rosa Alcaraz Peñarrocha, Juan Carlos Ruiz Rodriguez, Xavier Nuvials Casals, Judith Sacanell Lacasa, Marcos Pérez Carrasco, José Alonso Fajardo, Adolfo Ruiz Sanmartin, Óscar Mula Castellón, Anna Sánchez Corral, Elisabeth Papiol Gallofré, Luis silvestre Chiscano Camon, Eduard Argudo Serra, Maria Martinez Martinez, Jordi Riera del Brío, Raquel Albertos Martell, Noemí Varga , Sofia Contreras Medina, Andres Francisco Pacheco Reyes, Manuel Roberto Sosa Garay, Camilo andres Bonilla Rojas, Manuel Roberto Sosa Garay
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00798
Duration: 01/01/2022 - 30/06/2025

Valor diagnóstico de la plataforma molecular Biofire Filmarray en infecciones bacterianas del tracto respiratorio inferior asociadas a la ventilación mecánica: impacto en resultados clínicos

IP: Maria Martinez Martinez
Collaborators: -
Funding agency: FUNDACIÓN E.DEL ENFERMO CRÍTICO (FEEC)
Funding: 10000
Reference: FEEC/2021/MARTINEZ
Duration: 01/01/2022 - 31/12/2023

ADN CIRCULANTE COMO BIOMARCADOR NO INVASIVO TRAS UN TRASPLANTE DE PULMÓN

IP: Antonio Román Broto
Collaborators: Juliana Esperalba Esquerra, Carles Bravo Masgoret, Vanessa Casares Rodríguez, Judith Sacanell Lacasa, Cristina Berastegui Garcia, Manuel López Meseguer, Berta Saez Gimenez, Maria Martinez Martinez, Jordi Riera del Brío
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI17/01485
Duration: 01/01/2018 - 30/06/2022

Related news

The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital and will validate the prognostic value of the NLRP3 biomarker.

SOFA-2 is being updated after thirty years to incorporate advances in diagnosis, monitoring and life support.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Yesilkoy Filiz

Yesilkoy Filiz

Senior researcher
Microbiology
Read more
Ana Gallego Cortes

Ana Gallego Cortes

Postdoctoral researcher
Infectious Diseases
Read more
Marylin Riveiro Vilaboa

Marylin Riveiro Vilaboa

Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Alba Maria Jiménez Masip

Alba Maria Jiménez Masip

Predoctoral researcher
Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.